# Shenzhen Oriental Pharmaceutical Co Ltd, Guangdongsheng, China – FDA Inspections

Source: https://www.keypedia.com/companies/shenzhen-oriental-pharmaceutical-co-ltd/71227651-964f-4f33-a24b-5c0b0f6c92a0

> Inspection records and compliance data for Shenzhen Oriental Pharmaceutical Co Ltd in Guangdongsheng. 4 FDA inspections on record, 1 Form 483, last inspected November 29, 2024.

---

## Details

- Name: Shenzhen Oriental Pharmaceutical Co Ltd
- FEI Number: 3003677845
- Address Line 1: Longgang Street Da Lang Road
- City: Guangdongsheng
- Country Name: China
- Address: Longgang Street Da Lang Road, Guangdongsheng, China
- Country: China

## Related Documents

- [EIR - Shenzhen Oriental Pharmaceutical Co Ltd - 2024-11-29](https://www.keypedia.com/records/eir/shenzhen-oriental-pharmaceutical-co-ltd/f3ecf4dd-c30b-4eb7-903e-af7eff82a0eb) — source: FDA, date: November 29, 2024
- [FDA Inspection 1258257 - Shenzhen Oriental Pharmaceutical Co Ltd - 2024-11-29](https://www.keypedia.com/records/fda_inspections/shenzhen-oriental-pharmaceutical-co-ltd/f01fc07d-9b71-4d40-9aa8-b0593939811d) — source: FDA, date: November 29, 2024
- FDA Inspection 1258257 - Shenzhen Oriental Pharmaceutical Co Ltd - 2024-11-29 — classification: No Action Indicated (NAI), source: FDA, date: November 29, 2024
- [FDA Inspection 1080368 - Shenzhen Oriental Pharmaceutical Co Ltd - 2019-01-11](https://www.keypedia.com/records/fda_inspections/shenzhen-oriental-pharmaceutical-co-ltd/a3857e9b-ef9d-45e0-8bf3-00a592e74f77) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 11, 2019
- [483 - Shenzhen Oriental Pharmaceutical Co Ltd - 2019-01-07](https://www.keypedia.com/records/483/shenzhen-oriental-pharmaceutical-co-ltd/17c7343e-7e99-44ef-8c81-517170bd7508) — source: FDA, date: January 7, 2019
- FDA Inspection 976107 - Shenzhen Oriental Pharmaceutical Co Ltd - 2016-06-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 7, 2016
- FDA Inspection 872742 - Shenzhen Oriental Pharmaceutical Co Ltd - 2014-03-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 20, 2014

## Related Companies

- [Chengdu Shengnuo Biopharm Co Ltd](https://www.keypedia.com/companies/chengdu-shengnuo-biopharm-co-ltd/7e22dc83-be1b-41e1-af8c-856dd7a35375)
- [Henan Lihua Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/henan-lihua-pharmaceutical-co-ltd/0fcfa9cb-e461-4a79-b60a-20bd1198621a)
- [Kreative Organics Private Limited](https://www.keypedia.com/companies/kreative-organics-private-limited/a7ac8ac3-c335-4d67-ba2d-5cdc59181996)
- [SRI Krishna Pharmaceuticals Ltd - Unit I](https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-ltd-unit-i/a8609781-dc13-4ad6-9bb3-047ead2bf151)
- [Azico Biophore India Private Limited](https://www.keypedia.com/companies/azico-biophore-india-private-limited/373fe2a1-5910-425f-8478-71be63a40f32)
- [Yuki Gosei Kogyo Co., Ltd.](https://www.keypedia.com/companies/yuki-gosei-kogyo-co-ltd/94411f09-2744-47ca-9250-20774e61824e)
- [Cayman Chemical Company, Inc.](https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b)
- [Porton Pharma Solutions Ltd](https://www.keypedia.com/companies/porton-pharma-solutions-ltd/79b53452-47cf-4b03-a8a7-fae3ed70635b)
- [Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)](https://www.keypedia.com/companies/shandong-anxin-pharmaceutical-co-ltd-laoling-site/8ecae9ce-7b8b-40b5-99de-92a6859f9683)
- [Zhejiang Ausun Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-ausun-pharmaceutical-co-ltd/5c30ecf3-fdd1-4d64-833f-d28cc43b3da4)

## Related Officers

- [ Investigator ](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)
- [recipient](https://www.keypedia.com/people/miao-jin-chuan/39b73ce6-b7cc-41cd-9d68-7afaa4e416cc)
- [Drug Specialist](https://www.keypedia.com/people/lauren-n-howard/538f77fe-b977-49c9-a5b3-289cf8a6e886)